NCT02866097

Brief Summary

This study will provide important evidence to the Ministry of Community Development, Mother and Child Health (MCDMCH) and the Ministry of Health (MOH) on how to effectively implement iCCM with a focus on improving both the flow of supplies to CHWs as well as the quality of their supervision and mentorship. The overall aim will be to determine whether improvements in supplies for community health workers (CHWs) and strengthened supervision result in improved early and appropriate treatment for children with malaria, pneumonia, and diarrhea in rural Zambia when compared to CHWs offering iCCM without this logistics and supervision support.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
3,840

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Mar 2016

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

December 10, 2015

Completed
3 months until next milestone

Study Start

First participant enrolled

March 1, 2016

Completed
5 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 1, 2016

Completed
14 days until next milestone

First Posted

Study publicly available on registry

August 15, 2016

Completed
17 days until next milestone

Study Completion

Last participant's last visit for all outcomes

September 1, 2016

Completed
Last Updated

August 15, 2016

Status Verified

August 1, 2016

Enrollment Period

5 months

First QC Date

December 10, 2015

Last Update Submit

August 9, 2016

Conditions

Keywords

integrated community case managementMobile Health (mHealth)rapid diagnostic testartemether-lumefantrineamoxicillinzincoral rehydration solution (ORS)District Health Information System 2 (DHIS2)iCCM-DHIS2ZCAHRD

Outcome Measures

Primary Outcomes (1)

  • Composite percentage of children appropriately treated for malaria, diarrhea, and pneumonia.

    Defined as percentage of sick children under five years of age presenting with an i-CCM condition to an i-CCM trained health worker (CHW or a CHA) who received appropriate treatment for an iCCM condition (composite indicator): Appropriate treatment for malaria: received artemisinin-based combination therapy (ACT) for malaria for at least three days or Appropriate treatment for pneumonia: received amoxicillin for pneumonia for at least five days or Appropriate treatment for diarrhea: received zinc in addition to fluid from ORS packet or oral rehydration solution (ORS) liquid or homemade fluid for diarrhea

    Through study completion, up to six months

Secondary Outcomes (8)

  • a) Medicine availability (artemether-lumefantrine)

    Through study completion, up to six months

  • b) Clinical supervision coverage

    Through study completion, up to six months

  • c) Virtual supervision coverage (via mobile technology)

    Through study completion, up to six months

  • d) Average cost per iCCM contact

    Through study completion, up to six months

  • e) Diagnostic availability

    Through study completion, up to six months

  • +3 more secondary outcomes

Study Arms (2)

Intervention

EXPERIMENTAL

mHealth inventory management and referrals via text messaging plus supportive supervision of CHWs via an mHealth strategy

Other: mHealth inventory managementOther: Supportive supervision

Control

PLACEBO COMPARATOR

ICCM current standard of care with CHWs operating under standard conditions without enhanced inventory management or supportive supervision by mHealth

Other: ICCM current standard of care

Interventions

Improved stock management of iCCM commodities using the DHIS2 mHealth platform

Also known as: intervention
Intervention

Strengthening of supportive supervision using DHIS2

Also known as: intervention
Intervention

ICCM implementation as per current practice without mHealth interventions

Also known as: Control
Control

Eligibility Criteria

Age1 Month - 5 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)

You may qualify if:

  • Age \<5 years
  • Treatment for an iCCM condition (malaria, pneumonia, or diarrhea) by a CHW
  • Willingness of the child's caregiver to provide informed consent

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Chadiza and Chipata Districts

Chipata, Eastern Province, Zambia

RECRUITING

Related Publications (1)

  • Biemba G, Chiluba B, Yeboah-Antwi K, Silavwe V, Lunze K, Mwale RK, Hamer DH, MacLeod WB. Impact of mobile health-enhanced supportive supervision and supply chain management on appropriate integrated community case management of malaria, diarrhoea, and pneumonia in children 2-59 months: A cluster randomised trial in Eastern Province, Zambia. J Glob Health. 2020 Jun;10(1):010425. doi: 10.7189/jogh.10.010425.

MeSH Terms

Conditions

MalariaDiarrheaPneumoniaOsteoarthritis

Interventions

Methods

Condition Hierarchy (Ancestors)

Protozoan InfectionsParasitic DiseasesInfectionsMosquito-Borne DiseasesVector Borne DiseasesSigns and Symptoms, DigestiveSigns and SymptomsPathological Conditions, Signs and SymptomsRespiratory Tract InfectionsLung DiseasesRespiratory Tract DiseasesArthritisJoint DiseasesMusculoskeletal DiseasesRheumatic Diseases

Intervention Hierarchy (Ancestors)

Investigative Techniques

Study Officials

  • Godfrey Biemba, MBChB, M.Sc

    ZCAHRD and Boston University

    PRINCIPAL INVESTIGATOR
  • David Hamer, MD

    Boston University

    PRINCIPAL INVESTIGATOR
  • Boniface M Chiluba, B.Sc, M.Sc

    Zambia Center for Applied Health Research and Development

    STUDY DIRECTOR

Central Study Contacts

Godfrey Biemba, MBChB, M.Sc

CONTACT

Boniface M Chiluba, B.Sc, M.Sc

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
HEALTH SERVICES RESEARCH
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

December 10, 2015

First Posted

August 15, 2016

Study Start

March 1, 2016

Primary Completion

August 1, 2016

Study Completion

September 1, 2016

Last Updated

August 15, 2016

Record last verified: 2016-08

Data Sharing

IPD Sharing
Will share

The investigators will make the data available to outside parties upon receipt of an appropriate request detailing specific aims and an acceptable analysis plan.

Locations